Skip to Main Content

Paper Details

Compassionate Use of REGEN-COV® in Patients With Coronavirus Disease 2019 (COVID-19) and Immunodeficiency-Associated Antibody Disorders.
Clinical Infectious Diseases
7
2022
COV, COVID, COVID-19, COVID-19 infection, Coronavirus Disease 2019, Immunodeficiency-Associated Antibody Disorders, Patients, REGEN, casirivimab, immunodeficiency-associated antibody disorders, immunodeficient, patient, patients
Author NameAffiliation
George D YancopoulosRegeneron Pharmaceuticals, Inc.
  • 1 - 1

Datasets

Release 1.2